Francis André

3.9k total citations
78 papers, 2.8k citations indexed

About

Francis André is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Francis André has authored 78 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 34 papers in Infectious Diseases and 25 papers in Hepatology. Recurrent topics in Francis André's work include Viral gastroenteritis research and epidemiology (28 papers), Hepatitis B Virus Studies (27 papers) and Hepatitis Viruses Studies and Epidemiology (20 papers). Francis André is often cited by papers focused on Viral gastroenteritis research and epidemiology (28 papers), Hepatitis B Virus Studies (27 papers) and Hepatitis Viruses Studies and Epidemiology (20 papers). Francis André collaborates with scholars based in Belgium, Finland and Switzerland. Francis André's co-authors include Assad Safary, E. D'Hondt, Arie J. Zuckerman, A. Delem, A. Delem, Timo Vesikari, T. H. Flewett, G. M. Beards, Pierre Van Damme and G Wiedermann and has published in prestigious journals such as The Lancet, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Francis André

75 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis André Belgium 29 1.7k 1.4k 1.1k 403 349 78 2.8k
Ian D. Gust Australia 33 1.8k 1.1× 1.8k 1.3× 1.6k 1.4× 561 1.4× 103 0.3× 161 3.5k
P Morgan-Capner United Kingdom 36 2.0k 1.2× 293 0.2× 1.3k 1.2× 430 1.1× 540 1.5× 107 3.4k
Sue Ann Costa Clemens Italy 20 1.5k 0.9× 440 0.3× 798 0.7× 473 1.2× 193 0.6× 58 2.4k
Saul Krugman United States 34 3.0k 1.8× 1.5k 1.0× 1.0k 0.9× 224 0.6× 570 1.6× 103 4.0k
Hans L. Bock Belgium 24 999 0.6× 526 0.4× 646 0.6× 239 0.6× 213 0.6× 76 1.7k
Assad Safary Belgium 35 2.4k 1.4× 2.6k 1.9× 1.3k 1.1× 138 0.3× 456 1.3× 82 3.5k
Graham Tipples Canada 32 2.7k 1.6× 1.2k 0.9× 1.7k 1.5× 108 0.3× 209 0.6× 106 4.0k
T. Christopher Mast United States 25 1.2k 0.7× 499 0.4× 1.4k 1.2× 468 1.2× 110 0.3× 57 2.6k
P. J. Provost United States 21 1.6k 1.0× 1.5k 1.1× 1.0k 0.9× 274 0.7× 122 0.3× 40 2.4k
Barry D. Schoub South Africa 27 1.6k 0.9× 307 0.2× 1.1k 0.9× 334 0.8× 272 0.8× 119 2.5k

Countries citing papers authored by Francis André

Since Specialization
Citations

This map shows the geographic impact of Francis André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis André more than expected).

Fields of papers citing papers by Francis André

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis André. The network helps show where Francis André may publish in the future.

Co-authorship network of co-authors of Francis André

This figure shows the co-authorship network connecting the top 25 collaborators of Francis André. A scholar is included among the top collaborators of Francis André based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis André. Francis André is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richter, Darko, Ioana Anca, Francis André, et al.. (2014). Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations. Expert Review of Vaccines. 13(6). 801–815. 4 indexed citations
2.
Chlíbek, Roman, Ioana Anca, Francis André, et al.. (2010). Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination. Vaccine. 28(22). 3758–3766. 10 indexed citations
3.
André, Francis, et al.. (2006). Support of Open Archives at national level : the HAL experience. E-LIS Repository (University of Naples Federico II).
4.
André, Francis. (2006). Universal Mass Vaccination Against Hepatitis A. Current topics in microbiology and immunology. 304. 95–114. 27 indexed citations
5.
André, Francis. (2005). What can be done to make vaccines more trendy?. Expert Review of Vaccines. 4(1). 23–25. 5 indexed citations
6.
André, Francis. (2004). Hepatitis B: A comprehensive prevention, diagnosis, and treatment program – past, present, and future. Journal of Gastroenterology and Hepatology. 19(S1). S1–4. 8 indexed citations
7.
André, Francis, et al.. (2002). Exogenous oestrogen as an alternative to food allergy in the aetiology of angioneurotic oedema. Toxicology. 185(1-2). 155–160. 14 indexed citations
8.
André, Francis. (2000). Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 18. S20–S22. 286 indexed citations
9.
Chang, Mei‐Hwei, et al.. (1993). Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers. Journal of Gastroenterology and Hepatology. 8(4). 338–341. 9 indexed citations
10.
Wiedermann, G, et al.. (1992). Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine. 10. S129–S131. 45 indexed citations
11.
Goubau, Patrick, Assad Safary, A. Delem, et al.. (1992). Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine. Vaccine. 10. S114–S118. 28 indexed citations
12.
André, Francis, E. D'Hondt, A. Delem, & Assad Safary. (1992). Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine. 10. S160–S168. 111 indexed citations
13.
14.
Schoub, Barry D., Sylvia Johnson, Johanna M. McAnerney, et al.. (1990). Measles, mumps and rubella immunization at nine months in a developing country. The Pediatric Infectious Disease Journal. 9(4). 263–267. 21 indexed citations
15.
Wiedermann, G, F Ambrosch, Herwig Kollaritsch, et al.. (1990). Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine. 8(6). 581–584. 69 indexed citations
16.
Ruuska, Tarja, Timo Vesikari, A. Delem, et al.. (1990). Evaluation of RIT 4237 Bovine Rotavirus Vaccine in Newborn Infants: Correlation of Vaccine Efficacy to Season of Birth in Relation to Rotavirus Epidemic Period. Scandinavian Journal of Infectious Diseases. 22(3). 269–278. 46 indexed citations
17.
Lanata, Claudio F., Robert E. Black, Roberto del Aguila, et al.. (1989). Protection of Peruvian Children Against Rotavirus Diarrhea of Specific Serotypes by One, Two, or Three Doses of the RIT 4237 Attenuated Bovine Rotavirus Vaccine. The Journal of Infectious Diseases. 159(3). 452–459. 106 indexed citations
18.
Wiedermann, G, Otto Scheiner, F Ambrosch, et al.. (1988). Lack of Induction of IgE and IgG Antibodies to Yeast in Humans Immunized with Recombinant Hepatitis B Vaccines. International Archives of Allergy and Immunology. 85(1). 130–132. 15 indexed citations
19.
André, Francis & Assad Safary. (1987). Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine.. PubMed. 63 Suppl 2. 169–77. 73 indexed citations
20.
Vesikari, Timo, Erika Isolauri, A. Delem, et al.. (1985). Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. The Journal of Pediatrics. 107(2). 189–194. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian D. Gust Breakdown of academic impact, for papers by P Morgan-Capner Breakdown of academic impact, for papers by Sue Ann Costa Clemens Breakdown of academic impact, for papers by Saul Krugman Breakdown of academic impact, for papers by Hans L. Bock Breakdown of academic impact, for papers by Assad Safary Breakdown of academic impact, for papers by Graham Tipples Breakdown of academic impact, for papers by T. Christopher Mast Breakdown of academic impact, for papers by P. J. Provost Breakdown of academic impact, for papers by Barry D. Schoub
Rankless by CCL
2026